Prognostic Value of Genotype-Phenotype Correlations in X-Linked Myotubular Myopathy and the Use of the Face2Gene Application as an Effective Non-Invasive Diagnostic Tool

Genes (Basel). 2023 Dec 3;14(12):2174. doi: 10.3390/genes14122174.

Abstract

Background: X-linked myotubular myopathy (XLMTM) is a rare congenital myopathy resulting from dysfunction of the protein myotubularin encoded by the MTM1 gene. XLMTM has a high neonatal and infantile mortality rate due to a severe myopathic phenotype and respiratory failure. However, in a minority of XLMTM cases, patients present with milder phenotypes and achieve ambulation and adulthood. Notable facial dysmorphia is also present.

Methods: We investigated the genotype-phenotype correlations in newly diagnosed XLMTM patients in a patients' cohort (previously published data plus three novel variants, n = 414). Based on the facial gestalt difference between XLMTM patients and unaffected controls, we investigated the use of the Face2Gene application.

Results: Significant associations between severe phenotype and truncating variants (p < 0.001), frameshift variants (p < 0.001), nonsense variants (p = 0.006), and in/del variants (p = 0.036) were present. Missense variants were significantly associated with the mild and moderate phenotype (p < 0.001). The Face2Gene application showed a significant difference between XLMTM patients and unaffected controls (p = 0.001).

Conclusions: Using genotype-phenotype correlations could predict the disease course in most XLMTM patients, but still with limitations. The Face2Gene application seems to be a practical, non-invasive diagnostic approach in XLMTM using the correct algorithm.

Keywords: DeepGestalt technology; Face2Gene application; MTM1 gene; X-linked myotubular myopathy; centronuclear myopathy; genotype–phenotype correlations; myotubularin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Association Studies
  • Humans
  • Infant, Newborn
  • Mutation, Missense*
  • Myopathies, Structural, Congenital* / diagnosis
  • Myopathies, Structural, Congenital* / genetics
  • Phenotype
  • Prognosis

Grants and funding

Grant: APVV-17-0296, APVV-22-257.